Allergan Tanks to 5-Year Low as Botox Rivalry Heats with Mylan
Mizuho I Investor's Business Daily
Allergan (AGN) tanked to a five-year low Thursday after Mylan (MYL) and Revance Therapeutics (RVNC) announced their plan to bring a Botox copycat to the market just as U.S. regulators imposed a delay on an Allergan drug.
Why Valeant Pharma Might Be Wearing Rose-Colored Glasses
Mizuho I Investor's Business Daily
Broadway Technology connects to Moscow Exchange
Broadway Technology I FinExtra
Fintech infrastructure solutions provider Broadway Technology and Moscow Exchange have announced that Broadway Technology has begun offering its clients access to Moscow Exchange’s FX Market.
Broadway Technology to offer FX connectivity to the Moscow Exchange for international investors
Broadway Technology I LeapRate
TrueEX branches out to Asia as Singapore opens path for platforms
trueEX I Global Capital
Salesforce Earnings: Expectations are high for the Dreamforce Quarter
Mizuho I MarketWatch